Pediatric Disorders of Water Balance

Pediatric Clinics of North America

Volumn 58, Issue 5, 2011, Pages 1271-1280

  Ranadive, Sayali A ^a   Rosenthal, Stephen M ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes insipidus; Hypernatremia; Hyponatremia; SIADH

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; AQUAPORIN 2; BROMOCRIPTINE; CARBAMAZEPINE; CLOFIBRATE; CYCLIC AMP; CYCLOPHOSPHAMIDE; DEMECLOCYCLINE; DESMOPRESSIN; FUROSEMIDE; HALOPERIDOL; LITHIUM; LORCAINIDE; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; OPIATE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SODIUM ION; THIORIDAZINE; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; UREA; VASOPRESSIN; VASOPRESSIN DERIVATIVE; VASOPRESSIN V2 RECEPTOR; VINBLASTINE; VINCRISTINE;

ANTIDIURESIS; CHILD; DIABETES INSIPIDUS; DIURESIS; ELECTROLYTE DISTURBANCE; FLUID BALANCE; FLUID INTAKE; FLUID THERAPY; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY EPITHELIUM; REVIEW; THIRST; WATER PERMEABILITY; X CHROMOSOME;

EID: 80053600480     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.07.013     Document Type: Review

References (45)

1. Robertson G.L. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 2001, 30(3):671-694. vii.
2. Robinson A.G., Verbalis J.G. Posterior pituitary gland. Williams textbook of endocrinology 2003, 281-329. Saunders, Philadelphia. 10th edition. P.R. Larsen, H.M. Kronenberg, S. Melmed (Eds.).
3. Rutishauser J., Kopp P., Gaskill M.B., et al. Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene. Eur J Endocrinol 2002, 146(5):649-656.
4. Lederis K., Jayasena K. Storage of neurohypophysial hormones and the mechanism for their release. Pharmacology of the endocrine system and related drugs 1970, 111-154. Pergamon, London. H. Heller, B.T. Pickering (Eds.).
5. Roberts M.M., Robinson A.G., Hoffman G.E., et al. Vasopressin transport regulation is coupled to the synthesis rate. Neuroendocrinology 1991, 53(4):416-422.
6. Muglia L.J., Majzoub J.A. Disorders of the posterior pituitary. Pediatric endocrinology 2002, 289-322. Saunders, Philadelphia. M.A. Sperling (Ed.).
7. Baylis P.H., Thompson C.J. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf) 1988, 29(5):549-576.
8. Schrier R.W., Cadnapaphornchai M.A. Renal aquaporin water channels: from molecules to human disease. Prog Biophys Mol Biol 2003, 81(2):117-131.
9. Baylis P.H., Cheetham T. Diabetes insipidus. Arch Dis Child 1998, 79(1):84-89.
10. Verbalis J.G. Diabetes insipidus. Rev Endocr Metab Disord 2003, 4(2):177-185.
11. Morello J.P., Bichet D.G. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001, 63:607-630.
12. Spanakis E., Milord E., Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol 2008, 217(3):605-617.
13. Bichet D.G., Birnbaumer M., Lonergan M., et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 1994, 55(2):278-286.
14. Wenkert D., Schoneberg T., Merendino J.J., et al. Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol 1996, 124(1-2):43-50.
15. Pasel K., Schulz A., Timmermann K., et al. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab 2000, 85(4):1703-1710.
16. Bernier V., Bichet D.G., Bouvier M. Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol 2004, 4(5):528-533.
17. Morello J.P., Salahpour A., Laperriere A., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000, 105(7):887-895.
18. Bernier V., Morello J.P., Zarruk A., et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2006, 17(1):232-243.
19. Kirchlechner V., Koller D.Y., Seidl R., et al. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 1999, 80(6):548-552.
20. van Lieburg A.F., Knoers N.V., Monnens L.A. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1999, 10(9):1958-1964.
21. Knoers N.V., Deen P.M. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001, 16(12):1146-1152.
22. Kennedy G.C., Crawford J.D. Treatment of diabetes insipidus with hydrochlorothiazide. Lancet 1959, 1(7078):866-867.
23. Alon U., Chan J.C. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 1985, 5(1):9-13.
24. Knoers N., Monnens L.A. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr 1990, 117(3):499-502.
25. Ranadive S.A., Ersoy B., Favre H., et al. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) 2009, 71:388-393.
26. Serradeil-Le Gal C., Wagnon J., Valette G., et al. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res 2002, 139:197-210.
27. Miller W.L. Molecular genetics of familial central diabetes insipidus. J Clin Endocrinol Metab 1993, 77(3):592-595.
28. Gagliardi P.C., Bernasconi S., Repaske D.R. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23→Val in neurophysin II. J Clin Endocrinol Metab 1997, 82(11):3643-3646.
29. Willcutts M.D., Felner E., White P.C. Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum Mol Genet 1999, 8(7):1303-1307.
30. Maghnie M., Cosi G., Genovese E., et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000, 343(14):998-1007.
31. Mootha S.L., Barkovich A.J., Grumbach M.M., et al. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997, 82(5):1362-1367.
32. Alter C.A., Bilaniuk L.T. Utility of magnetic resonance imaging in the evaluation of the child with central diabetes insipidus. J Pediatr Endocrinol Metab 2002, 15(Suppl 2):681-687.
33. Ghirardello S., Garre M.L., Rossi A., et al. The diagnosis of children with central diabetes insipidus. J Pediatr Endocrinol Metab 2007, 20(3):359-375.
34. Fujisawa I., Nishimura K., Asato R., et al. Posterior lobe of the pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr 1987, 11(2):221-225.
35. Gudinchet F., Brunelle F., Barth M.O., et al. MR imaging of the posterior hypophysis in children. AJR Am J Roentgenol 1989, 153(2):351-354.
36. Brooks B.S., el Gammal T., Allison J.D., et al. Frequency and variation of the posterior pituitary bright signal on MR images. AJNR Am J Neuroradiol 1989, 10(5):943-948.
37. Alonso G., Bergada I., Heinrich J.J. An Esp Pediatr 2000, 53(2):100-105. [in Spanish].
38. Kubota T., Yamamoto T., Ozono K., et al. Hyperintensity of posterior pituitary on MR T1WI in a boy with central diabetes insipidus caused by missense mutation of neurophysin II gene. Endocr J 2001, 48(4):459-463.
39. Maghnie M., Genovese E., Bernasconi S., et al. Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. AJNR Am J Neuroradiol 1997, 18(9):1749-1752.
40. Bartter F.C., Schwartz W.B. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967, 42(5):790-806.
41. Verbalis J.G., Goldsmith S.R., Greenberg A., et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120(11 Suppl 1):S1-S21.
42. Baylis P.H. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003, 35(11):1495-1499.
43. Feldman B.J., Rosenthal S.M., Vargas G.A., et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005, 352(18):1884-1890.
44. Cogan E., Debieve M.F., Pepersack T., et al. Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. Am J Med 1988, 84(3 Pt 1):409-418.
45. Huang E.A., Feldman B.J., Schwartz I.D., et al. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 2006, 148(1):128-131.